PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31470141-0	2019	Reversine inhibits MMP-3, IL-6 and IL-8 expression through suppression of ROS and JNK/AP-1 activation in interleukin-1beta-stimulated human gingival fibroblasts.	2-(4-morpholinoanilino)-6-cyclohexylaminopurine	0-9	mitogen-activated protein kinase 8	Homo sapiens	82-85	
30087398-0	2018	Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1.	2-(4-morpholinoanilino)-6-cyclohexylaminopurine	0-9	mitogen-activated protein kinase 8	Homo sapiens	63-67	
30087398-5	2018	A coupled kinase assay with bio-informatics approach identified the c-Jun N-terminal kinase (JNK) cascade as the main pathway inhibited by Reversine.	2-(4-morpholinoanilino)-6-cyclohexylaminopurine	139-148	mitogen-activated protein kinase 8	Homo sapiens	68-91	
30087398-5	2018	A coupled kinase assay with bio-informatics approach identified the c-Jun N-terminal kinase (JNK) cascade as the main pathway inhibited by Reversine.	2-(4-morpholinoanilino)-6-cyclohexylaminopurine	139-148	mitogen-activated protein kinase 8	Homo sapiens	93-96	
30087398-8	2018	These results highlight the impact of individual JNK isoforms in cancer cell metastasis and propose Reversine as a novel anti-cancer molecule for treatment of colon cancer patients.	2-(4-morpholinoanilino)-6-cyclohexylaminopurine	100-109	mitogen-activated protein kinase 8	Homo sapiens	49-52